LACHEN, Switzerland--(BUSINESS WIRE)--2009 for Octapharma continued the focus on consolidation with the introduction of our own plasma production, resulting in investments exceeding €135M. Against this backdrop, for the fifth consecutive year, Octapharma realised a record turnover and profit. Our Net turnover passed the mark of 1 billion at €1,009M equivalent to an increase of 14% over €886M in 2008.
